6 results
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Venous Thrombosis ... - Arterial Thrombosis ... management #EULAR2019 #guidelines ... #rheumatology # ... hematology #treatment
Venous Thrombosis vs Arterial Thrombosis - Differential Diagnosis Framework

VENOUS THROMBOSIS

 • Acquired Risk Factors:
	- >48 hours
• Nephrotic Syndrome ... Arterial Embolism ... fibrillation ... Malignancy - Antiphospholipid ... #Venous #Arterial
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
Syndrome (APS) ... to be present Treatment ... (EULAR Guidelines ... #Syndrome #APS ... #guidelines
Mesenteric Ischemia - Differential Diagnostic Schema
Chronic: ASCVD, Venous, Vasculitides 5% (PAN, [E]GPA, IgA, MPA)
Acute
 - Venous
pancreatitis) - Arterial ... - Thrombus / Embolism ... akinesis), ASCVD, Antiphospholipid ... syndrome, Endovasc ... hypovolemia), Meds/Treatments
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... randomized controlled trial ... PE = pulmonary embolism ... mass index; VTE = venous ... Cancer #Algorithm #Anticoagulation
Cryofibrinogenemia Summary

Cryofibrinogenemia Epidemiology:
 • 40-70 years with a modest female predominance

Cryofibrinogenemia:
 • The precipitation of a
and/or venous occlusions ... HUS and HIT • Antiphospholipid ... syndrome • Warfarin-induced ... DIC • Septic emboli ... Cryofibrinogenemia #diagnosis #rheumatology